基于自动分割MRI图像的影像组学特征:三阴性乳腺癌新辅助化疗后的预后生物标志物
回顾性纳入2009年1月至2018年12月接受新辅助化疗的147例三阴性乳腺癌患者,利用深度学习分割模型在化疗前、后动态增强MRI上自动勾画肿瘤并提取影像组学特征,建立化疗前、化疗后及两者联合的三种影像组学模型预测全身复发;联合模型在测试集AUC为0.933,优于临床模型,DeLong检验显示差异有统计学意义(p<0.05)。
要点
- 联合化疗前、后MRI影像组学特征的模型3预测全身复发测试集AUC为0.933,优于临床模型。
- 基于化疗后MRI的模型2测试集AUC为0.802,基于化疗前MRI的模型1测试集AUC为0.814。
- 临床模型训练集AUC为0.747、测试集AUC为0.737,所有影像组学模型测试集AUC均高于临床模型。
核心结论
- 基于化疗前与化疗后MRI特征联合构建的影像组学模型在预测TNBC患者新辅助化疗后3年内是否发生全身复发方面表现良好,有助于无创识别高危复发患者以加强随访和治疗。
研究设计与样本
- 回顾性研究,纳入2009年1月至2018年12月接受新辅助化疗的147例三阴性乳腺癌患者,随机分为训练集104例(复发22例、未复发82例)和测试集43例(复发9例、未复发34例);采用深度学习分割模型在化疗前、后动态增强MRI图像上自动分割肿瘤区域并提取影像组学特征,以受试者工作特征曲线分析评估模型性能。
诊断标准与关键数值
- 临床模型预测全身复发训练集AUC为0.747、测试集AUC为0.737;模型1(基于化疗前MRI特征)训练集AUC为0.879、测试集AUC为0.814;模型2(基于化疗后MRI特征)训练集AUC为0.91、测试集AUC为0.802;模型3(基于化疗前和化疗后MRI特征)训练集AUC为0.963、测试集AUC为0.933。
临床应用与阅片要点
- 作者认为该模型可无创识别新辅助化疗后高复发风险的三阴性乳腺癌患者,从而加强这些患者的随访和治疗,可能改善预后。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To establish radiomics prediction models based on automatic segmented magnetic resonance imaging (MRI) for predicting the systemic recurrence of triple-negative breast cancer (TNBC) in patients after neoadjuvant chemotherapy (NAC).
MATERIALS AND METHODS: A total of 147 patients with TNBC who underwent NAC between January 2009 and December 2018 were enrolled in this study. Clinicopathologic data were collected, and the differences between the recurrent and nonrecurrent patients were analyzed by univariate and multivariate analyses. Patients were randomly divided into training and testing sets. The training set consisted of 104 patients (recurrence: 22, nonrecurrence: 82), and the testing set consisted of 43 patients (recurrence: 9, nonrecurrence: 34). To establish the radiomics prediction model, we used a deep learning segmentation model to automatically segment tumor areas on dynamiccontrast-enhanced-MRI images of pre- and post-NAC magnetic resonance examinations. Radiomics features were then extracted from the tumor areas. Three MRI radiomics models were developed in the training set: a radiomics model based on pre-NAC MRI features (model 1), a radiomics model based on post-NAC MRI features (model 2), and a radiomics model based on both pre- and post-NAC MRI features (model 3). A clinical model for predicting systemic recurrence was built in the training set using independent clinical prediction factors. Receiver operating characteristic curve analysis was used to evaluate the performance of the radiomics and clinical models.
RESULTS: The clinical model yielded areas under the curve (AUCs) of 0.747 in the training set and 0.737 in the testing set in terms of predicting systemic recurrence. Models 1, 2, and 3 yielded AUCs of 0.879, 0.91, and 0.963 in the training set and 0.814, 0.802, and 0.933 in the testing set, respectively, in terms of predicting systemic recurrence. All of the radiomics models had achieved higher AUCs than the clinical model in the testing set. DeLong test was used to compare the AUCs between the models and indicated that the predictive performance of model 3 was better than the clinical model, and the difference was statistically significant (p < 0.05).
CONCLUSION: The radiomics models built based on the combination of pre- and post-NAC MRI features showed good performance in predicting whether patients with TNBC will have systemic recurrence within 3 years post-NAC. This can help us non-invasively identify which patients are at high risk of recurrence post-NAC, so that we can strengthen follow-up and treatment of these patients. Then the prognosis of these patients might be improved.
引用
- Ma, Gan, Liu, et al. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy. Eur J Radiol. 2021. PMID: 34890936. doi:10.1016/j.ejrad.2021.110095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。